Pavel Osmancik

[on-hold music] Welcome to The Lead, the podcast of the HRS.

I am Dr. Cinzia Monaco, and today we are discussing the paper Pulse Field Ablation versus Sham to Treat Atrial Fibrillation, the PFA Sham Randomized Clinical Trial by Pavel Osmancik and colleagues, published in circulation this June.

This is the first sham-controlled trial of pulse field ablation and the second sham-controlled AF ablation trial ever.

Testing the question, how much of ablation's benefit, especially in quality of life, is real, and how much is placebo? And to discuss it, I am delighted to be joined by Dr.